XTX Topco’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,195
| Closed | -$24.7K | – | 2244 |
|
|
2023
Q4 | $24.7K | Sell |
1,195
-1,638
| -58% | -$33.9K | 0.01% | 1339 |
|
|
2023
Q3 | $90.1K | Sell |
2,833
-2,108
| -43% | -$67K | 0.02% | 1197 |
|
|
2023
Q2 | $166K | Buy |
+4,941
| New | +$166K | 0.03% | 1073 |
|
|
2023
Q1 | – | Sell |
-6,226
| Closed | -$211K | – | 1609 |
|
|
2022
Q4 | $211K | Sell |
6,226
-165
| -3% | -$5.59K | 0.04% | 808 |
|
|
2022
Q3 | $314K | Buy |
6,391
+3,910
| +158% | +$192K | 0.08% | 471 |
|
|
2022
Q2 | $97K | Sell |
2,481
-1,573
| -39% | -$61.5K | 0.04% | 655 |
|
|
2022
Q1 | $150K | Buy |
4,054
+2,934
| +262% | +$109K | 0.07% | 459 |
|
|
2021
Q4 | $110K | Buy |
+1,120
| New | +$110K | 0.06% | 455 |
|
|
2021
Q3 | – | Sell |
-1,063
| Closed | -$133K | – | 1011 |
|
|
2021
Q2 | $133K | Buy |
+1,063
| New | +$133K | 0.04% | 626 |
|